Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
LEVOFLOXACIN
Generics (UK) Limited
J01MA12
LEVOFLOXACIN
250/50 Mg/Ml
Solution for Infusion
Product subject to prescription which may not be renewed (A)
Fluoroquinolones
Authorised
2010-05-21
PACKAGE LEAFLET: INFORMATION FOR THE USER LEVOFLOXACIN 250 MG/50 ML, SOLUTION FOR INFUSION LEVOFLOXACIN 500 MG/100 ML, SOLUTION FOR INFUSION Levofloxacin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, nurse or pharmacist. - If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. WHAT IS IN THIS LEAFLET: 1. What Levofloxacin is and what it is used for 2. What you need to know before you are given Levofloxacin 3. How Levofloxacin is given 4. Possible side effects 5. How to store Levofloxacin 6. Contents of the pack and other information 1. WHAT LEVOFLOXACIN IS AND WHAT IT IS USED FOR The name of your medicine is Levofloxacin. Levofloxacin contains a medicine called levofloxacin. This belongs to a group of medicines called antibiotics. Levofloxacin is a ‘quinolone’ antibiotic. It works by killing the bacteria that cause infections in your body. LEVOFLOXACIN CAN BE USED TO TREAT INFECTIONS OF THE: - Lungs, in people with pneumonia - Urinary tract, including your kidneys or bladder - Prostate gland, where you have a long lasting infection - Skin and underneath the skin, including muscles. This is sometimes called ‘soft tissue’ In some special situations, levofloxacin may be used to lessen the chances of getting a pulmonary disease named anthrax or worsening of the disease after you are exposed to the bacteria causing anthrax. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN LEVOFLOXACIN DO NOT HAVE THIS MEDICINE AND TELL YOUR DOCTOR IF: You are allerg Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Levofloxacin 250 mg/50 ml, solution for infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 50 ml of solution for infusion contains 250 mg of levofloxacin as levofloxacin hemihydrate. Excipients with known effect: 50 ml of solution for infusion contains 7.7 mmol (177 mg) of sodium. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for infusion. Clear greenish-yellow isotonic solution with a pH of 4.3 to 5.3 and an osmolality between 280 and 320 mOsm/Kg. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Levofloxacin is indicated in adults for the treatment of the following infections (see sections 4.4 and 5.1): • Community-acquired pneumonia • Complicated skin and soft tissue infections For the above-mentioned infections levofloxacin should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of these infections. • Pyelonephritis and complicated urinary tract infections (see section 4.4) • Chronic bacterial prostatitis • Inhalation Anthrax: postexposure prophylaxis and curative treatment (see section 4.4). Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Levofloxacin is administered by slow intravenous infusion once or twice daily. The dosage depends on the type and severity of the infection and the susceptibility of the presumed causative pathogen. Treatment with levofloxacin after initial use of the intravenous preparation may be completed with an appropriate oral presentation according to the SPC for the film-coated tablets and as considered appropriate for the individual patient. Given the bioequivalence of Read the complete document